Skip to main content
    P

    ProMIS Neurosciences Inc. (PMN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.21
    -0.10 (-3.02%)

    Market Cap: $29.60M

    Last updated: Nov 17, 2026 at 4:23 PM ET

    ProMIS Neurosciences Inc. (PMN) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    ProMIS Neurosciences (PMN) has a market cap of $29.60M. Its share count is up 368.08% from a year earlier. It holds $44.07M more cash than debt, 148.90% of its market cap.

    Total Valuation

    Market Cap$29.60M
    Latest price (Nov 17, 2026)$3.21

    Key Dates

    The next earnings report is expected on Mar 23, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 23, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.01% in the quarter ended Sep 30, 2026 and shrank 44.82% a year over 2 years.

    Shares Outstanding9.14M
    Shares Change (YoY)+368.08%
    Shares Change (QoQ)+0.01%
    Share Count Growth (2Y CAGR)-44.82%

    Price Statistics

    The stock is down 67.04% over 52 weeks and trades 63.52% below its 50-day average.

    Beta (1Y)1.99
    52-Week Change-67.04%
    1-Month Change-61.00%
    3-Month Change-78.10%
    6-Month Change-69.86%
    5-Year Change-99.98%
    10-Year Change-99.96%
    Total Return (1Y)-67.04%
    Total Return (3Y CAGR)-54.35%
    Total Return (5Y CAGR)-55.83%
    Return vs SPY (1Y)-76.20%
    Max Drawdown (1Y)-87.90%
    Max Drawdown (3Y)-95.73%
    Sharpe Ratio (1Y)-0.67
    Correlation with SPY (1Y)0.17
    50-Day Average$8.80
    200-Day Average$12.49
    52-Week Range$2.78 to $27.40
    RSI (14 Days)30.2
    Average Volume (20 Days)427.58K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 8.83x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio8.83x
    Quick Ratio8.83x
    Debt / Equity0.00x
    Interest Coverage37.20x

    Returns and Efficiency

    Return on equity is -92.93% and return on assets is -82.29% over the last 12 months.

    Return on Equity (ROE)-92.93%
    Return on Assets (ROA)-82.29%
    Return on Capital Employed (ROCE)-92.82%

    Scores

    PMN has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Operating Income-$40.30M
    Pretax Income-$38.82M
    Net Income-$38.81M
    EBITDA-$38.82M
    EBIT-$38.82M
    Reported EPS (TTM)-$33.48

    Trailing 12 months through Sep 30, 2026.

    Balance Sheet

    Shareholder equity funds 88.55% of the $47.16M in total assets.

    Cash and Equivalents$44.07M
    Total Debt$0
    Net Cash$44.07M
    Net Cash Per Share$4.82
    Working Capital$41.82M
    Shareholder Equity$41.76M
    Book Value Per Share$4.57
    Total Assets$47.16M
    Total Liabilities$5.40M

    Balance sheet as of Sep 30, 2026.

    Cash Flow

    Operating Cash Flow-$41.43M
    FCF Per Share-$4.62

    Trailing 12 months through Sep 30, 2026.

    Dividends and Yields

    PMN does not pay a dividend.

    Buyback Yield-238.85%
    Shareholder Yield-238.85%

    Stock Splits

    The last split was a 1-for-25 reverse split on Nov 28, 2025.

    Last Split DateNov 28, 2025
    Split TypeReverse split
    Split Ratio1:25

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About PMN

    What is PMN's market cap?

    ProMIS Neurosciences has a market cap of $29.60M.

    How many shares of PMN are outstanding?

    ProMIS Neurosciences has 9.14M shares outstanding. The count is up 368.08% from a year earlier.

    Does PMN pay a dividend?

    No. ProMIS Neurosciences does not pay a dividend.

    How much debt does PMN have?

    ProMIS Neurosciences has $0 of total debt and $44.07M of cash and equivalents, a net cash position of $44.07M.